JUBILANT PHARMOVA
Back to Income Statement
|
JUBILANT PHARMOVA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹7,235 Cr | ₹6,703 Cr | ₹6,282 Cr | ₹6,130 Cr | ₹6,099 Cr |
What is the latest Revenue of JUBILANT PHARMOVA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹7,235 Cr |
| Mar2024 | ₹6,703 Cr |
| Mar2023 | ₹6,282 Cr |
| Mar2022 | ₹6,130 Cr |
| Mar2021 | ₹6,099 Cr |
How is Revenue of JUBILANT PHARMOVA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,235 Cr | 7.93 | |
| Mar2024 | ₹6,703 Cr | 6.71 | |
| Mar2023 | ₹6,282 Cr | 2.47 | |
| Mar2022 | ₹6,130 Cr | 0.52 | |
| Mar2021 | ₹6,099 Cr | - | |
Compare Revenue of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹15,324.7 Cr | -6.1% | -1.1% | -19.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | -6.1% |
-1.1% |
-19.1% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses